Sysmex (OTCMKTS:SSMXY) Sets New 12-Month High – Still a Buy?

Sysmex Corporation ADR (OTCMKTS:SSMXY)’s stock price reached a new 52-week high on Thursday. The stock traded as high as $13.01 and last traded at $13.01, with a volume of 6,074 shares changing hands. The stock had previously closed at $12.1850.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded shares of Sysmex from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 18th. Two investment analysts have rated the stock with a Hold rating. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold”.

Sysmex Trading Up 2.9%

The firm has a market cap of $7.97 billion, a price-to-earnings ratio of 31.19 and a beta of 1.20. The firm’s fifty day moving average is $11.98 and its 200-day moving average is $10.01. The company has a debt-to-equity ratio of 0.23, a current ratio of 3.40 and a quick ratio of 2.53.

Sysmex (OTCMKTS:SSMXY) last issued its quarterly earnings data on Friday, August 7th. The company reported $0.09 EPS for the quarter, topping analysts’ consensus estimates of $0.07 by $0.02. Sysmex had a return on equity of 8.01% and a net margin of 7.62%. The firm had revenue of $825.85 million during the quarter, compared to analyst estimates of $741.67 million. Equities analysts anticipate that Sysmex Corporation ADR will post 0.41 earnings per share for the current year.

Sysmex Company Profile

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and distributes clinical laboratory instruments, reagents and related information systems. Its products are used by hospitals, diagnostic laboratories and other healthcare providers to support the analysis of blood, urine and other biological samples.

The company is best known for its hematology analyzers, which help laboratories evaluate blood cells and identify conditions such as anemia and leukemia.